Fierce Pharma

NOVEMBER 28, 2023

. | Monday, during the first meeting of the new White House Council on Supply Chain Resilience, President Biden unveiled nearly 30 actions to bolster production networks across industries.

Manufacturing 218

Manufacturing Networking Medicine 218

MedCity News

DECEMBER 20, 2023

NourishedRx is joining ProHealth Connect’s network, meaning its nutrition offerings are accessible for members of 46 payers with food benefits through a ProHealth Connect OTC or flex card. These members will be able to receive NourishedRx’s food delivery services and its wraparound support.

Food 305

Food Networking Medicine 305

Pharmaceutical Technology

MAY 18, 2023

The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain.

Medicine 99

Medicine Specialization Networking Patients 99

European Pharmaceutical Review

MAY 22, 2024

The agencies holding this status have been approved and validated as compliant and committed to upholding the “highest level of regulatory standards and practices for quality, safety and efficacy of medicines and vaccines ”.

Medicine 93

Medicine Leads Food and Drug Administration Safety 93

pharmaphorum

JANUARY 24, 2023

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Medicines and medical technology manufacturing delivered annual exports worth over £30 billion ($37 billion) for the UK in 2019, on top of making a £32.1 It’s not all bad news.

Manufacturing 111

Manufacturing Medicine Government Pharmaceutical manufacturing 111

MedCity News

JANUARY 12, 2023

M&A activity among health systems picked up last year — key trends included cross-market mega-mergers and academic medical centers expanding their community hospital networks. Despite tough economic conditions, Kaufman Hall experts expect this activity to continue growing in 2023.

Networking 278

Networking Medical Marketing Medicine 278

European Pharmaceutical Review

NOVEMBER 15, 2023

Sandoz] has the only major remaining vertically-integrated production network for penicillins in Europe” Penicillins are the leading category of antibiotics worldwide, Sandoz highlighted. The post Sandoz mobilises critical medicine production in Europe appeared first on European Pharmaceutical Review.

Medicine 93

Medicine Manufacturing Networking Biopharma 93

European Pharmaceutical Review

JUNE 17, 2024

Johnson & Johnson Innovative Medicine is planning to invest a total of €580 million in Italy over the next five years. A portion of the investment, €125 million, is intended to support greater production capacity at its Latina site, which is a key part of the firm’s worldwide supply chain network, the company stated.

Medicine 97

Medicine Manufacturing Management Government 97

PharmaTech

DECEMBER 27, 2023

The midterm report of the European Medicines Agencies Network Strategy finds that the network has strengthened and is on track to achieve its objectives.

Networking 52

Networking Medicine 52

Legacy MEDSearch

DECEMBER 7, 2022

Medical device and technology company Lazurite has received recognition from Medical Device Network Excellence Awards & Rankings, one of the largest, most prestigious, and widely recognized programs in the industry. All Commended companies will be entered into the Medical Device Network Awards at the end of the year. “The

Networking 98

Networking Medical Food and Drug Administration Recruitment 98

Evolve Your Success

NOVEMBER 14, 2023

One of those is sports medicine. As we celebrate International Men’s Day, Samuel Adeyinka interviews Jordan Rawlins about the world of orthopedics, namely sports medicine. What are the different roles in sports medicine medical sales and what do you need to prepare to ensure success in this space? It’s network.

Medical sales 130

Medical sales Medicine Sales Medical 130

European Pharmaceutical Review

AUGUST 23, 2022

FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. Some, 250,000 child deaths per year can be attributed to counterfeit malaria and pneumonia medicines. The prevalence of fake drugs is a continually growing problem worldwide.

Medicine 98

Medicine Food and Drug Administration Pharmaceutical products Pharmaceutical 98

PharmaTech

MARCH 24, 2025

The EU medicines agencies network strategy, EMANS, is an update of the five-year strategy previously developed to cover the period 2021 to 2025.

Networking 52

Networking Medicine 52

InCrowd

MARCH 15, 2023

Despite the American Academy of Sleep Medicine ’s recent “Defend your Sleep” and “Sleep is Good Medicine” campaigns, most of my patients have never been educated in sleep hygiene. This includes basic yet critical behaviors like going to bed and, most importantly, waking up, at the same time every day.

Physicians 246

Physicians Patients Education Healthcare 246

pharmaphorum

OCTOBER 25, 2024

GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.The programme represents the largest capital spend by the UK drugmaker on production capacity to date and will double the size and capacity of GSK's existing medicines and vaccines facility in Marietta, Pennsylvania, (..)

Manufacturing 112

Manufacturing Networking Medicine 112

European Pharmaceutical Review

OCTOBER 10, 2024

A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). The EMA highlighted that advances in technology such as artificial intelligence (AI) has created opportunities to transform medicine development and regulation.

Medicine 98

Medicine Networking Competition Pharmaceutical 98

European Pharmaceutical Review

NOVEMBER 21, 2024

In his over 11-year tenure at Pfizer thus far, Dr Boshoff he has delivered 24 approved innovative medicines and biosimilars in over 30 indications, according to Pfizer. “Dr Academy of Medical Sciences. “I Furthermore, Dr Roger Dansey will become Interim Chief Oncology Officer, from 1 January 2025.

Medicine 59

Medicine Medical science Biopharma Medical 59

Pharma Marketing Network

NOVEMBER 23, 2024

From AI-powered insights to the rise of precision medicine, new trends are reshaping the way we connect with patients and healthcare providers. Precision Medicine: Targeting the Right Audience Precision medicine, with its focus on individualized treatment, offers a goldmine of opportunities for marketers.

Marketing 52

Marketing Pharma Ethics Healthcare Provider 52

pharmaphorum

FEBRUARY 2, 2024

The PM Society are delighted to be running their fifth Careers Conference that will be taking place on the 21st of February 2024 between 1pm to 6pm at the Royal Society of Medicine. Please share with your colleagues and network, as this is a great opportunity for students to attend and learn more about our industry.

Networking 98

Networking Medicine 98

European Pharmaceutical Review

MARCH 21, 2024

million strategic initiative is set to support UK advanced therapy medicinal product (ATMP) clinical trials, and help the region maintain its position as a leader in clinical research. An additional four years of funding for the Advanced Therapy Treatment Centre ( ATTC ) network is available through this programme.

Networking 105

Networking Medicine Medical Pharmaceutical 105

World of DTC Marketing

DECEMBER 20, 2021

Research published in the New England Journal of Medicine shows that a value-based healthcare model can help solve the cost and quality problems that plague the U.S. This means that primary, specialty, and acute care are integrated and that healthcare providers work as a networked team to deliver the best-coordinated care.

Healthcare 209

Healthcare Healthcare Insurance Prescription 209

World of DTC Marketing

AUGUST 7, 2022

Researchers with Aimed Alliance , a non-profit that seeks to protect and enhance the rights of health care consumers and providers, say that doctors are so fed up with the constant headaches caused by insurers that two-thirds would recommend against pursuing a career in medicine. Nearly half (48%) are considering a career change altogether.

Insurance 263

Insurance Doctors Government Physicians 263

European Pharmaceutical Review

DECEMBER 7, 2023

A report from the Advanced Therapies Treatment Centre (ATTC) Network has highlighted urgent need for rapid change and improvement in the field to maximise patient access to advanced therapies. It was compiled based on expertise gathered at the ATTC Network’s UK Advanced Therapies Adoption Challenge event in October.

Networking 98

Networking Medicine Leads Manufacturing 98

European Pharmaceutical Review

NOVEMBER 2, 2022

The clinic will develop pre-clinical studies into early and late phase clinical trials to identify US Food and Drug Administration (FDA)-approved advanced regenerative medicines. The Cedars-Sinai Board of Governors Regenerative Medicine Institute and the Smidt Heart Institute will lead the project. Scientific and operational teams.

Food and Drug Administration 98

Food and Drug Administration Medicine Training Electronics 98

European Pharmaceutical Review

APRIL 28, 2023

The network aims to build a comprehensive contextual understanding of situational data in each National Hub to identify opportunities to address existing gaps and challenges. Each hub has specific and complementary multidisciplinary research expertise.

Networking 98

Networking Medicine Leads Pharmaceutical 98

Clarify Health

MARCH 19, 2024

At the forefront of this revolution is the rising use of various types of healthcare provider data and deep analytics to assess provider performance and build cost-effective, quality networks. According to the National Academy of Medicine , quality healthcare involves many characteristics, including effectiveness, timeliness, and efficiency.

Networking 52

Networking Healthcare Healthcare Healthcare Provider 52

European Pharmaceutical Review

MAY 10, 2023

Dr Florian Bieber, Development Platform Head, Biopharmaceuticals, and Chief Medical Officer of Sandoz stated that investment will help to position the site as part of a “growing network of BioTD centres.” These conditions include rheumatic diseases, Crohn’s disease, ulcerative colitis (UC), plaque psoriasis and hidradenitis suppurativa.

Manufacturing 98

Manufacturing Medicine Networking Biopharma 98

Nixon Gwilt Law

JULY 26, 2024

Food as Medicine (FaM), also referred to as ‘Food Is Medicine’ or ‘Food Is Health,’ is playing a significant role in the ever-evolving healthcare landscape. How Food as Medicine Programs are Reimbursed Insurance reimbursement, a primary method of payment for healthcare providers, is evolving in the FaM space.

Food 52

Food Medicine Insurance Retail 52

Nixon Gwilt Law

JULY 26, 2024

Food as Medicine (FaM), also referred to as ‘Food Is Medicine’ or ‘Food Is Health,’ is playing a significant role in the ever-evolving healthcare landscape. How Food as Medicine Programs are Reimbursed Insurance reimbursement, a primary method of payment for healthcare providers, is evolving in the FaM space.

Food 52

Food Medicine Insurance Retail 52

European Pharmaceutical Review

DECEMBER 30, 2024

A 2023 report by the Alliance for Regenerative Medicine identified skills gaps in analytical development and testing, quality control, and manufacturing of cell and gene therapies 3 a gap which is expected to widen in the coming years. Internet] Alliance for Regenerative Medicine. References 1. Tomtishen J. 2023; 29:SP4278.

Manufacturing 52

Manufacturing Food and Drug Administration Medicine Training 52

pharmaphorum

FEBRUARY 28, 2024

Ginkgo Bioworks builds its drug discovery toolkit again, making three acquisitions and launching a partner network in AI, genetic medicines, manufacturing and other areas

Networking 76

Networking Manufacturing Medicine 76

European Pharmaceutical Review

SEPTEMBER 7, 2022

The 2022-2026 workplan of the initiative Accelerating Clinical Trials in the EU ( ACT EU ) has been published by the European Commission (EC), Heads of Medicines Agencies (HMA) and European Medicines Agency (EMA).

Medicine 105

Medicine Training Networking Pharmaceutical 105

European Pharmaceutical Review

JUNE 2, 2023

The Centre for Process Innovation (CPI) is set to establish a new UK Intracellular Drug Delivery Centre to develop new lipid nanoparticle (LNP) formulations for RNA medicine delivery, and a framework to advance next-generation nano delivery systems.

Manufacturing 105

Manufacturing Medicine Training Networking 105

European Pharmaceutical Review

SEPTEMBER 13, 2023

The new expansion will strengthen MSD’s global manufacturing capabilities to meet increased demand for MSD’s medicines and vaccines. This recent investment will significantly accelerate the time it takes to bring a medicine to market, according to MSD Ireland. MSD Dunboyne in Co.

Manufacturing 98

Manufacturing Medicine Engineering Networking 98

Eversana Intouch

NOVEMBER 16, 2023

The annual event assembled nearly 1,000 attendees from over 40+ countries across the healthcare ecosystem to learn, network and explore industry challenges, strategic trends and solutions in life sciences and healthcare. Last week, Frontiers Health, the premier global digital health innovation event, was held in Rome, Italy.

Healthcare 105

Healthcare Healthcare Medicine Marketing 105

European Pharmaceutical Review

DECEMBER 23, 2022

With over 90,000 employees across the globe, Sanofi supplies over 5 billion doses of medicines and vaccines every year, supporting the health needs of millions of patients in more than 170 countries. This will not only transform the practice of medicine, but will transform ourselves as an organisation. Standardise manufacturing .

Manufacturing 98

Manufacturing Networking Medicine Electronics 98

European Pharmaceutical Review

DECEMBER 2, 2022

The investment will support the addition of new technologies to ensure Pfizer is ready to facilitate the next generation of medical innovations, and to help increase capacity for licensed and pipeline products in oncology, rare disease, inflammation & immunology and internal medicines. The facility is planned for completion in 2027.

Manufacturing 105

Manufacturing Medicine Networking Medical 105